Autonomic nervous system dysfunction in chronic obstructive pulmonary disease: mechanistic insights and therapeutic implications.

Researchers reviewed existing studies to understand how nervous system problems contribute to chronic obstructive pulmonary disease (COPD), a serious lung condition that makes breathing difficult. They found that COPD involves an imbalance in the autonomic nervous system—the part of your nervous system that automatically controls breathing, heart rate, and other vital functions. Specifically, people with COPD often have too much activity in the parasympathetic nervous system (which causes airways to narrow and produce excess mucus) and not enough activity in the sympathetic nervous system (which normally helps open airways). This imbalance not only worsens breathing problems but also contributes to other health issues like heart disease. The review identified several promising treatments that target this nervous system dysfunction, including newer approaches like vagus nerve stimulation and targeted lung nerve procedures. Importantly for acupuncture patients, the researchers specifically mentioned that traditional approaches including acupuncture show effectiveness in improving functional outcomes for COPD patients. This suggests that acupuncture may help restore balance to the autonomic nervous system, potentially easing breathing difficulties and improving overall quality of life. The study emphasizes that future COPD treatment should focus on personalized interventions based on each patient's specific nervous system dysfunction pattern. If you have COPD and are considering acupuncture, consult with a licensed acupuncturist experienced in treating respiratory conditions.

This narrative review analyzed preclinical and clinical studies from PubMed and Web of Science examining autonomic nervous system (ANS) dysfunction in COPD pathophysiology. The authors identified key mechanisms including cholinergic hyperactivity driving bronchoconstriction and mucus hypersecretion, sympathetic suppression impairing bronchodilation, and neuroimmune crosstalk linking pulmonary and systemic complications. Specific sample sizes and effect sizes were not provided in this review article. Emerging therapeutic strategies discussed include bioelectronic neuromodulation (vagus nerve stimulation for inflammation reduction), targeted lung denervation for exacerbation reduction in specific phenotypes, and traditional interventions including acupuncture demonstrating efficacy in functional outcome improvement. Clinical takeaway: ANS dysregulation represents a therapeutic target in COPD management. Precision modulation through phenotype-specific interventions, including acupuncture, may address both pulmonary symptoms and extrapulmonary comorbidities. Practitioners should consider autonomic dysfunction as part of comprehensive COPD treatment planning, particularly for patients with cardiovascular comorbidities or frequent exacerbations.